MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 28 filers reported holding MOLECULIN BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $139,000 | -2.1% | 175,000 | 0.0% | 0.00% | – |
| Q3 2020 | $142,000 | +5.2% | 175,000 | +25.0% | 0.00% | – |
| Q2 2020 | $135,000 | +58.8% | 140,000 | 0.0% | 0.00% | – |
| Q1 2020 | $85,000 | -33.6% | 140,000 | 0.0% | 0.00% | – |
| Q4 2019 | $128,000 | -17.4% | 140,000 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $155,000 | -11.4% | 140,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $175,000 | +54.9% | 140,000 | 0.0% | 0.00% | +50.0% |
| Q1 2019 | $113,000 | +20.2% | 140,000 | +55.6% | 0.00% | 0.0% |
| Q4 2018 | $94,000 | -34.7% | 90,000 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $144,000 | -10.6% | 90,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $161,000 | -0.6% | 90,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $162,000 | -3.0% | 90,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $167,000 | -22.3% | 90,000 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $215,000 | +28.0% | 90,000 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $168,000 | +257.4% | 90,000 | +125.0% | 0.00% | +200.0% |
| Q1 2017 | $47,000 | +2.2% | 40,000 | +100.0% | 0.00% | 0.0% |
| Q4 2016 | $46,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitegate Investment Counselors, Inc. | 101,781 | $81,000 | 0.01% |
| Levy Wealth Management Group, LLC | 14,036 | $11,000 | 0.01% |
| WOODMONT INVESTMENT COUNSEL LLC | 12,000 | $10,000 | 0.00% |
| Renaissance Technologies | 948,503 | $756,000 | 0.00% |
| Qube Research & Technologies Ltd | 132,238 | $105,000 | 0.00% |
| Core Wealth Advisors, Inc. | 1,711 | $1,000 | 0.00% |
| UBS Group AG | 36,726 | $29,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| Squarepoint Ops LLC | 12,342 | $10,000 | 0.00% |
| TRUE Private Wealth Advisors | 2,500 | $1,000 | 0.00% |